Hemispherx (HEB) Shares Tumble Amid Class Action Lawsuit by Shareholders
Shares of the volatile Hemispherx BioPharma (AMEX: HEB) are selling-off today as, last night, Dyer & Berens announced that it has filed a class action lawsuit on Hemispherx related to violations of the federal Securities Exchange Act of 1934. The stock most recently traded at $1.09, down 9.2% from yesterday's closing price.
Specifically, the suit, filed with a District Court in Eastern Pennsylvania, is on behalf of all purchasers of Hemispherx's securities between February 18, 2009 and October 30, 2009.
Notably, the stock has already been traded 2.15 million times, which compares to its average daily volume of about 3.3 million shares. Shares of Hemispherx fell more than 2% yesterday.
Related Categories
Corporate NewsMomentum Movers
Stocks Mentioned
Comments
HEB / DIBBS
Anyone remember screen name "DIBBS" he pimped HEB like no other, made his $$ and screwed. Could he have been a plant?? He she be looked at as well
Lost lots of money
Hi Adam, I have lost almost 10k in HEB because of the misleading information they have been providing. How can I participate in lawsuit against HEB
Adamis an honest man
Adam F is the only one who said the truth and every body made fun of him
Adam F
I think it's time to investigate Adam. You and your group seem to be responsible for many bogus law suits such as this one. I have called several federal law enforcement agencies, because the SEC is so obviously compromised. It's a matter of time before one picks this up.
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

I lost $20,000 already
Samuel on Nov 12, 2009 07:47 PMI don't want to read any more reviews on bogus stocks, only review the real companies that have a real product and a real chance for approval. So many biotech scams need to be weeded out for investors.